Skip to main content
logo
Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
1.390
-0.180 (-11.46%)
Feb 12, 2026, 9:30 AM EST

Genscript Biotech Revenue

Genscript Biotech had revenue of $518.77M in the half year ending June 30, 2025, with 32.57% growth. This brings the company's revenue in the last twelve months to $828.10M, up 63.20% year-over-year. In the year 2024, Genscript Biotech had annual revenue of $594.49M with 6.07% growth.

Revenue (ttm)
828.10M
Revenue Growth
+63.20%
P/S Ratio
4.18
Revenue / Employee
143.54K
Employees
5,769
Market Cap
3.46B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024594.49M34.01M6.07%
Dec 31, 2023560.48M-65.22M-10.42%
Dec 31, 2022625.70M135.60M27.67%
Dec 31, 2021490.10M99.25M25.39%
Dec 31, 2020390.85M117.49M42.98%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
ZIVO Bioscience209.03K
Revenue Rankings

Genscript Biotech News

More News